Timothy Richard Coon

This inventor holds 26 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Cystic Fibrosis Research. Top assignees: Vertex Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., Boehringer Ingelheim International Gmbh. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy Richard Coon. Retrieved from https://idiyas.com/inventor/timothy-richard-coon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 12)

EPO Patents = 9 (Patent Applications = 18)

Average Co-Inventor Count = 14.7

ph-index = 7

Forward Citations = 166(Granted Patents)

Company Filing History:

15 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

11 out of 123

Neurocrine Biosciences, Inc.

patents

1 out of 1,561

Boehringer Ingelheim International Gmbh

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Cystic Fibrosis

CFTR Modulators

Pharmaceutical Compositions

Gonadotropin-Releasing Hormone

Receptor Antagonists

Crystalline Forms

Methods of Treatment

Sleep Inducing Compounds

Processes of Making

Compounds

Modulators

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12324802 - Modulators of cystic fibrosis transmembrane conductance regulator (2025-06-10),

2. 12319693 - Crystalline forms of CFTR modulators (2025-06-03),

3. 12269831 - Modulators of cystic fibrosis transmembrane conductance regulator (2025-04-08),

4. 12168009 - Modulators of cystic fibrosis transmembrane conductance regulator (2024-12-17),

5. 12122788 - Process of making CFTR modulators (2024-10-22),

6. 11873300 - Crystalline forms of CFTR modulators (2024-01-16),

7. 11866450 - Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators (2024-01-09),

8. 11713324 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2023-08-01),

9. 11591350 - Modulators of cystic fibrosis transmembrane conductance regulator (2023-02-28),

10. 11584761 - Process of making CFTR modulators (2023-02-21),

11. 11426407 - Modulators of cystic fibrosis transmembrane conductance regulator (2022-08-30),

12. 11066417 - Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators (2021-07-20),

13. 10941159 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2021-03-09),

14. 10758534 - Modulators of cystic fibrosis transmembrane conductance regulator (2020-09-01),

15. 10738030 - Modulators of cystic fibrosis transmembrane conductance regulator (2020-08-11),

Title: The Innovative Journey of Inventor Timothy Richard Coon

Introduction:

Timothy Richard Coon, a prolific inventor based in Carlsbad, CA (US), has made remarkable contributions to the field of pharmaceuticals with a total of 21 patents under his belt.

Latest Patents:

Coon's latest patents showcase his expertise in the area of CFTR modulators, including crystalline forms of Compound I and modulators of Cystic Fibrosis Transmembrane Conductance regulator. These patents highlight his dedication to developing pharmaceutical compositions for the treatment of cystic fibrosis.

Career Highlights:

With a background in pharmaceuticals, Coon has previously worked at renowned companies such as Neurocrine Biosciences, Inc. and Vertex Pharmaceuticals, Inc. His innovative spirit and commitment to advancing medical treatments have significantly impacted the industry.

Collaborations:

Throughout his career, Coon has collaborated with esteemed professionals in the field, including coworkers like Mark Thomas Miller and Jeremy J Clemens. These collaborations have led to the development of groundbreaking solutions in the realm of pharmaceutical research.

Conclusion:

Timothy Richard Coon's unwavering passion for innovation and his relentless pursuit of excellence have solidified his position as a pioneering figure in the pharmaceutical industry. His extensive patent portfolio and collaborative efforts continue to inspire advancements in the field, paving the way for transformative treatments for various medical conditions.

Profile summary based on public USPTO records.